Abstract:Abstract Background Mesenchymal stromal cells, which can be obtained in a large quantity from bone marrow easily, are non-hematopoietic multipotent stem cells that cannot differentiate into hematopoietic components in physiological condition. Induced pluripotent hematopoietic stem cells (iP-HSCs) may be an alternative graft source for autologous hematopoietic stem cell transplantation (HSCT) without malignant cell contamination and provide a disease-specific model for studying the underlying pathogenesis. This study aimed to generate putative induced pluripotent stem cells (iPSCs) from bone marrow-derived MSCs (BM-MSCs) using the plasmid pcDNA3.1, only containing OCT4. Methods BM-MSCs with stable ectopic OCT4 expression were established using a conventional plasmid vector, and then cultured in ES medium to form ESC-like clones. The obtained putative iPSCs were divided into two groups and treated with two different growth factor cocktails to induce differentiation into hematopoietic progenitor cells. Furthermore, putative iPSCs were injected subcutaneously into nude mice and the resulting cells were analyzed. Results The generated putative iPSCs were similar to human embryonic stem cells (ESCs) in terms of morphology, surface marker expression, telomerase activity and in vitro differentiation. CD34 + progenitor cells were obtained from the putative iPSCs following treatment with specific factors. The proportion of CD34 + progenitor cells were higher in differentiated cells (16.16 ± 1.27% and 25.40 ± 3.08% at days 14 and 21, respectively) compared to that of untransfected parental BM-MSCs (0.93 ± 0.46%) or undifferentiated cells (1.58 ± 1.29%) (P < 0.05) as determined using flow cytometry. After induction using the second growth factor cocktail and induction process,, the proportion of CD34 + cells reached 31.39 ± 3.60% and 73.68 ± 6.63% at days 14 and 21, respectively. These differentiated cells expressed the mesodermal hematopoietic transcription factor Brachyury. Conclusions This cell induction system developed in this study may provide a possible source of grafts-enriched CD34 + progenitor cells without malignant cell contamination for clinical use and to generate patient-specific cell models for studying of the mechanisms of hematopoiesis and related diseases.

Hypoxia Promotes Thyroid Differentiation of Native Murine Induced Pluripotent Stem Cells.

A Comparison of Murine Smooth Muscle Cells Generated from Embryonic Versus Induced Pluripotent Stem Cells

Experimental Study on Directed Differentiation of Embryonic Stem Cells into Thyrocyte-Like Cells in Vitro

Directed differentiation of embryonic stem cells towards thyroid cells in vitro

Promotion of the Induction of Cell Pluripotency Through Metabolic Remodeling by Thyroid Hormone Triiodothyronine-Activated PI3K/AKT Signal Pathway

Differentiation of E14 Mouse Embryonic Stem Cells into Thyrocytes in Vitro

Effect and Mechanism of Hypoxia on Differentiation of Porcine-Induced Pluripotent Stem Cells into Vascular Endothelial Cells

Modeling Human Thyroid Development by Fetal Tissue‐Derived Organoid Culture

Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism

The thyroid hormone enhances mouse embryonic fibroblasts reprogramming to pluripotent stem cells: role of the nuclear receptor corepressor 1

Introduction of OCT4 into Human Bone-Marrow Derived Mesenchymal Stromal Cells Generates Putative Ips Cells with the Potential to Differentiate into CD34+ Hematopoietic Progenitor Cells Ex Vivo

Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions.

Hypoxia-Induced miR-210 Overexpression Promotes the Differentiation of Human-Induced Pluripotent Stem Cells to Hepatocyte-Like Cells on Random Nanofiber Poly-L-Lactic Acid/Poly (ε-Caprolactone) Scaffolds

Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated Thyroid Cancer

Microencapsulation of Porcine Thyroid Cell Organoids Within A Polymer Microcapsule Construct

Modelling Functional Thyroid Follicular Structures Using P19 Embryonal Carcinoma Cells

FoxO1 Inhibition Promotes Differentiation of Human Embryonic Stem Cells into Insulin Producing Cells.

Mechanism Study for Hypoxia Induced Differentiation of Insulin-Producing Cells from Umbilical Cord Blood-Derived Mesenchymal Stem Cells

HIF-1α Affects the Neural Stem Cell Differentiation of Human Induced Pluripotent Stem Cells via MFN2-Mediated Wnt/β-Catenin Signaling

Biphasic Modulation of Insulin Signaling Enables Highly Efficient Hematopoietic Differentiation from Human Pluripotent Stem Cells.

Thyroid hormone T3 induces Fyn modification and modulates palmitoyltransferase gene expression through αvβ3 integrin receptor in PC12 cells during hypoxia